nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—PTPRS—prostate gland—prostate cancer	0.0362	0.229	CbGeAlD
Etidronic acid—ATP6V1A—prostate gland—prostate cancer	0.0209	0.132	CbGeAlD
Etidronic acid—PTPRS—ECM proteoglycans—LAMB2—prostate cancer	0.0193	0.0783	CbGpPWpGaD
Etidronic acid—PTPRS—bone marrow—prostate cancer	0.0186	0.118	CbGeAlD
Etidronic acid—PTPRS—ECM proteoglycans—DAG1—prostate cancer	0.0172	0.0698	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—LAMC1—prostate cancer	0.0164	0.0666	CbGpPWpGaD
Etidronic acid—PTPRS—testis—prostate cancer	0.0159	0.101	CbGeAlD
Etidronic acid—ATP6V1A—renal system—prostate cancer	0.0142	0.09	CbGeAlD
Etidronic acid—ATP6V1A—urethra—prostate cancer	0.014	0.0884	CbGeAlD
Etidronic acid—PTPRS—lymph node—prostate cancer	0.0116	0.0731	CbGeAlD
Etidronic acid—ATP6V1A—bone marrow—prostate cancer	0.0108	0.0681	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—EFEMP2—prostate cancer	0.00958	0.0389	CbGpPWpGaD
Etidronic acid—ATP6V1A—testis—prostate cancer	0.00919	0.0582	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—CAPNS1—prostate cancer	0.00854	0.0347	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—FBLN1—prostate cancer	0.00726	0.0295	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—KLK2—prostate cancer	0.00682	0.0277	CbGpPWpGaD
Etidronic acid—ATP6V1A—lymph node—prostate cancer	0.00666	0.0422	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—FBLN5—prostate cancer	0.00617	0.0251	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—ITGB3—prostate cancer	0.00582	0.0236	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—LAMB2—prostate cancer	0.0055	0.0223	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ADAM9—prostate cancer	0.0055	0.0223	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—DAG1—prostate cancer	0.0049	0.0199	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—LAMC1—prostate cancer	0.00468	0.019	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGA6—prostate cancer	0.00417	0.0169	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—SERPINE1—prostate cancer	0.00396	0.0161	CbGpPWpGaD
Etidronic acid—ATP6V1A—Insulin receptor recycling—INS—prostate cancer	0.00384	0.0156	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—BMP7—prostate cancer	0.00381	0.0155	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP7—prostate cancer	0.00354	0.0144	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—P4HB—prostate cancer	0.00333	0.0135	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP13—prostate cancer	0.00278	0.0113	CbGpPWpGaD
Etidronic acid—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—prostate cancer	0.00272	0.011	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CTSB—prostate cancer	0.00261	0.0106	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CTSD—prostate cancer	0.0026	0.0106	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—THBS1—prostate cancer	0.00256	0.0104	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—TGFB1—prostate cancer	0.0025	0.0102	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGFR4—prostate cancer	0.00226	0.00917	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00196	0.00796	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGF10—prostate cancer	0.00189	0.00767	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGB3—prostate cancer	0.00166	0.00674	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00155	0.00629	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGFR2—prostate cancer	0.00152	0.00615	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—KDR—prostate cancer	0.00141	0.00573	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ICAM1—prostate cancer	0.00135	0.00549	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00126	0.00513	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00123	0.005	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00123	0.005	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IRS1—prostate cancer	0.00121	0.00492	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CDH1—prostate cancer	0.0012	0.00486	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—INS—prostate cancer	0.00116	0.00471	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP2—prostate cancer	0.00115	0.00468	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—SERPINE1—prostate cancer	0.00113	0.00459	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—FGF2—prostate cancer	0.00109	0.00444	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAP2K1—prostate cancer	0.00108	0.0044	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGF2—prostate cancer	0.00103	0.00419	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SV2B—prostate cancer	0.00102	0.00414	CbGpPWpGaD
Etidronic acid—Risedronate—PTGS2—prostate cancer	0.00101	0.529	CrCbGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000999	0.00406	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—JAK2—prostate cancer	0.000989	0.00402	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AOX1—prostate cancer	0.000959	0.00389	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PGAM2—prostate cancer	0.000959	0.00389	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NAGLU—prostate cancer	0.000959	0.00389	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RFK—prostate cancer	0.000959	0.00389	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CB—prostate cancer	0.000939	0.00381	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000922	0.00374	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CASP3—prostate cancer	0.000916	0.00372	CbGpPWpGaD
Etidronic acid—Clodronate—PTGS2—prostate cancer	0.000896	0.471	CrCbGaD
Etidronic acid—ATP6V1A—Disease—HSD17B1—prostate cancer	0.000867	0.00352	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—DNAJC3—prostate cancer	0.000867	0.00352	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CTBP2—prostate cancer	0.000867	0.00352	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP9—prostate cancer	0.000866	0.00352	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—OR51E2—prostate cancer	0.00084	0.00341	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000814	0.00331	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000775	0.00315	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL17RD—prostate cancer	0.000773	0.00314	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—B4GALT4—prostate cancer	0.000773	0.00314	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BMPR1B—prostate cancer	0.000768	0.00312	CbGpPWpGaD
Etidronic acid—Constipation—Goserelin—prostate cancer	0.000747	0.00126	CcSEcCtD
Etidronic acid—Nausea—Bicalutamide—prostate cancer	0.000746	0.00126	CcSEcCtD
Etidronic acid—Pancytopenia—Docetaxel—prostate cancer	0.000745	0.00125	CcSEcCtD
Etidronic acid—Constipation—Conjugated Estrogens—prostate cancer	0.00074	0.00125	CcSEcCtD
Etidronic acid—Anaemia—Mitoxantrone—prostate cancer	0.000731	0.00123	CcSEcCtD
Etidronic acid—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000726	0.00122	CcSEcCtD
Etidronic acid—Arthralgia—Estradiol—prostate cancer	0.000722	0.00122	CcSEcCtD
Etidronic acid—Pancytopenia—Capecitabine—prostate cancer	0.000721	0.00121	CcSEcCtD
Etidronic acid—Feeling abnormal—Goserelin—prostate cancer	0.00072	0.00121	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Doxorubicin—prostate cancer	0.000717	0.00121	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Goserelin—prostate cancer	0.000714	0.0012	CcSEcCtD
Etidronic acid—Erythema multiforme—Etoposide—prostate cancer	0.000714	0.0012	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RGS17—prostate cancer	0.000714	0.0029	CbGpPWpGaD
Etidronic acid—Discomfort—Estradiol—prostate cancer	0.000714	0.0012	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—TGFB1—prostate cancer	0.000713	0.0029	CbGpPWpGaD
Etidronic acid—Oesophagitis—Doxorubicin—prostate cancer	0.000713	0.0012	CcSEcCtD
Etidronic acid—Rash maculo-papular—Doxorubicin—prostate cancer	0.000709	0.00119	CcSEcCtD
Etidronic acid—Leukopenia—Mitoxantrone—prostate cancer	0.000708	0.00119	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000707	0.00119	CcSEcCtD
Etidronic acid—Confusional state—Estradiol—prostate cancer	0.000698	0.00118	CcSEcCtD
Etidronic acid—Urticaria—Goserelin—prostate cancer	0.000694	0.00117	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000693	0.00117	CcSEcCtD
Etidronic acid—Abdominal pain—Goserelin—prostate cancer	0.00069	0.00116	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—WNT4—prostate cancer	0.000689	0.0028	CbGpPWpGaD
Etidronic acid—Infection—Estradiol—prostate cancer	0.000688	0.00116	CcSEcCtD
Etidronic acid—Urticaria—Conjugated Estrogens—prostate cancer	0.000687	0.00116	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Docetaxel—prostate cancer	0.000685	0.00115	CcSEcCtD
Etidronic acid—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000684	0.00115	CcSEcCtD
Etidronic acid—Vomiting—Ethinyl Estradiol—prostate cancer	0.000675	0.00114	CcSEcCtD
Etidronic acid—Arthralgia—Mitoxantrone—prostate cancer	0.000673	0.00113	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000671	0.00113	CcSEcCtD
Etidronic acid—Rash—Ethinyl Estradiol—prostate cancer	0.000669	0.00113	CcSEcCtD
Etidronic acid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000669	0.00113	CcSEcCtD
Etidronic acid—Alopecia—Etoposide—prostate cancer	0.000667	0.00112	CcSEcCtD
Etidronic acid—Discomfort—Mitoxantrone—prostate cancer	0.000665	0.00112	CcSEcCtD
Etidronic acid—Headache—Ethinyl Estradiol—prostate cancer	0.000665	0.00112	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Capecitabine—prostate cancer	0.000664	0.00112	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00066	0.00268	CbGpPWpGaD
Etidronic acid—Agranulocytosis—Docetaxel—prostate cancer	0.000653	0.0011	CcSEcCtD
Etidronic acid—Confusional state—Mitoxantrone—prostate cancer	0.000651	0.0011	CcSEcCtD
Etidronic acid—Hypersensitivity—Goserelin—prostate cancer	0.000644	0.00108	CcSEcCtD
Etidronic acid—Infection—Mitoxantrone—prostate cancer	0.000641	0.00108	CcSEcCtD
Etidronic acid—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000637	0.00107	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RLN2—prostate cancer	0.000636	0.00258	CbGpPWpGaD
Etidronic acid—Muscle spasms—Etoposide—prostate cancer	0.000632	0.00106	CcSEcCtD
Etidronic acid—Agranulocytosis—Capecitabine—prostate cancer	0.000632	0.00106	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000631	0.00106	CcSEcCtD
Etidronic acid—Nausea—Ethinyl Estradiol—prostate cancer	0.00063	0.00106	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—prostate cancer	0.000623	0.00253	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000623	0.00253	CbGpPWpGaD
Etidronic acid—Paraesthesia—Estradiol—prostate cancer	0.000622	0.00105	CcSEcCtD
Etidronic acid—Pruritus—Goserelin—prostate cancer	0.000618	0.00104	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—RPL12—prostate cancer	0.000618	0.00251	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—LDHB—prostate cancer	0.000618	0.00251	CbGpPWpGaD
Etidronic acid—Pruritus—Conjugated Estrogens—prostate cancer	0.000612	0.00103	CcSEcCtD
Etidronic acid—Osteoarthritis—Epirubicin—prostate cancer	0.000612	0.00103	CcSEcCtD
Etidronic acid—Dyspepsia—Estradiol—prostate cancer	0.00061	0.00103	CcSEcCtD
Etidronic acid—Anaemia—Etoposide—prostate cancer	0.000608	0.00102	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CTBP2—prostate cancer	0.000607	0.00247	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HSD17B1—prostate cancer	0.000607	0.00247	CbGpPWpGaD
Etidronic acid—Diarrhoea—Goserelin—prostate cancer	0.000598	0.00101	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000594	0.00241	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Docetaxel—prostate cancer	0.000594	0.000999	CcSEcCtD
Etidronic acid—Constipation—Estradiol—prostate cancer	0.000592	0.000997	CcSEcCtD
Etidronic acid—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000592	0.000997	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Prednisone—prostate cancer	0.000591	0.000995	CcSEcCtD
Etidronic acid—Leukopenia—Etoposide—prostate cancer	0.000589	0.000991	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000588	0.00099	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TCN2—prostate cancer	0.000586	0.00238	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PLXNB1—prostate cancer	0.000582	0.00236	CbGpPWpGaD
Etidronic acid—Paraesthesia—Mitoxantrone—prostate cancer	0.000579	0.000975	CcSEcCtD
Etidronic acid—Erythema multiforme—Capecitabine—prostate cancer	0.000575	0.000968	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CA—prostate cancer	0.000572	0.00232	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Estradiol—prostate cancer	0.000571	0.000961	CcSEcCtD
Etidronic acid—Dyspepsia—Mitoxantrone—prostate cancer	0.000568	0.000956	CcSEcCtD
Etidronic acid—Osteoarthritis—Doxorubicin—prostate cancer	0.000566	0.000954	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Estradiol—prostate cancer	0.000566	0.000953	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GRPR—prostate cancer	0.00056	0.00228	CbGpPWpGaD
Etidronic acid—Vomiting—Goserelin—prostate cancer	0.000555	0.000935	CcSEcCtD
Etidronic acid—Alopecia—Docetaxel—prostate cancer	0.000555	0.000934	CcSEcCtD
Etidronic acid—Discomfort—Etoposide—prostate cancer	0.000553	0.000931	CcSEcCtD
Etidronic acid—Constipation—Mitoxantrone—prostate cancer	0.000552	0.000929	CcSEcCtD
Etidronic acid—Rash—Goserelin—prostate cancer	0.000551	0.000927	CcSEcCtD
Etidronic acid—Dermatitis—Goserelin—prostate cancer	0.00055	0.000926	CcSEcCtD
Etidronic acid—Vomiting—Conjugated Estrogens—prostate cancer	0.00055	0.000926	CcSEcCtD
Etidronic acid—Urticaria—Estradiol—prostate cancer	0.00055	0.000926	CcSEcCtD
Etidronic acid—Abdominal pain—Estradiol—prostate cancer	0.000547	0.000922	CcSEcCtD
Etidronic acid—Headache—Goserelin—prostate cancer	0.000547	0.000921	CcSEcCtD
Etidronic acid—Erythema—Docetaxel—prostate cancer	0.000546	0.00092	CcSEcCtD
Etidronic acid—Rash—Conjugated Estrogens—prostate cancer	0.000546	0.000919	CcSEcCtD
Etidronic acid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000545	0.000918	CcSEcCtD
Etidronic acid—Headache—Conjugated Estrogens—prostate cancer	0.000542	0.000913	CcSEcCtD
Etidronic acid—Gastritis—Epirubicin—prostate cancer	0.000542	0.000912	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—IL17RD—prostate cancer	0.000541	0.0022	CbGpPWpGaD
Etidronic acid—Confusional state—Etoposide—prostate cancer	0.000541	0.000911	CcSEcCtD
Etidronic acid—Hallucination—Prednisone—prostate cancer	0.000539	0.000907	CcSEcCtD
Etidronic acid—Alopecia—Capecitabine—prostate cancer	0.000537	0.000904	CcSEcCtD
Etidronic acid—Infection—Etoposide—prostate cancer	0.000533	0.000898	CcSEcCtD
Etidronic acid—Feeling abnormal—Mitoxantrone—prostate cancer	0.000532	0.000895	CcSEcCtD
Etidronic acid—Erythema—Capecitabine—prostate cancer	0.000529	0.000891	CcSEcCtD
Etidronic acid—Asthma—Epirubicin—prostate cancer	0.000529	0.000891	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000528	0.000888	CcSEcCtD
Etidronic acid—Muscle spasms—Docetaxel—prostate cancer	0.000525	0.000885	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000525	0.00213	CbGpPWpGaD
Etidronic acid—Flatulence—Capecitabine—prostate cancer	0.000521	0.000878	CcSEcCtD
Etidronic acid—Nausea—Goserelin—prostate cancer	0.000519	0.000874	CcSEcCtD
Etidronic acid—Nausea—Conjugated Estrogens—prostate cancer	0.000514	0.000865	CcSEcCtD
Etidronic acid—Urticaria—Mitoxantrone—prostate cancer	0.000513	0.000863	CcSEcCtD
Etidronic acid—Hypersensitivity—Estradiol—prostate cancer	0.00051	0.000859	CcSEcCtD
Etidronic acid—Abdominal pain—Mitoxantrone—prostate cancer	0.00051	0.000859	CcSEcCtD
Etidronic acid—Muscle spasms—Capecitabine—prostate cancer	0.000509	0.000857	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6—prostate cancer	0.000507	0.00206	CbGpPWpGaD
Etidronic acid—Anaemia—Docetaxel—prostate cancer	0.000505	0.00085	CcSEcCtD
Etidronic acid—Pancytopenia—Epirubicin—prostate cancer	0.000502	0.000846	CcSEcCtD
Etidronic acid—Gastritis—Doxorubicin—prostate cancer	0.000501	0.000844	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000499	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—GSTO1—prostate cancer	0.000498	0.00202	CbGpPWpGaD
Etidronic acid—Pruritus—Estradiol—prostate cancer	0.00049	0.000825	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—prostate cancer	0.000489	0.000824	CcSEcCtD
Etidronic acid—Leukopenia—Docetaxel—prostate cancer	0.000489	0.000824	CcSEcCtD
Etidronic acid—Anaemia—Capecitabine—prostate cancer	0.000489	0.000823	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—WNT4—prostate cancer	0.000482	0.00196	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JUP—prostate cancer	0.000482	0.00196	CbGpPWpGaD
Etidronic acid—Paraesthesia—Etoposide—prostate cancer	0.000482	0.000811	CcSEcCtD
Etidronic acid—Alopecia—Prednisone—prostate cancer	0.000478	0.000806	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—LRP2—prostate cancer	0.000477	0.00194	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Mitoxantrone—prostate cancer	0.000475	0.0008	CcSEcCtD
Etidronic acid—Diarrhoea—Estradiol—prostate cancer	0.000474	0.000798	CcSEcCtD
Etidronic acid—Leukopenia—Capecitabine—prostate cancer	0.000474	0.000797	CcSEcCtD
Etidronic acid—Erythema—Prednisone—prostate cancer	0.000471	0.000794	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—EIF2AK2—prostate cancer	0.000468	0.0019	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPL10—prostate cancer	0.000468	0.0019	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—P4HB—prostate cancer	0.000468	0.0019	CbGpPWpGaD
Etidronic acid—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000468	0.000787	CcSEcCtD
Etidronic acid—Arthralgia—Docetaxel—prostate cancer	0.000465	0.000783	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—prostate cancer	0.000465	0.000783	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Epirubicin—prostate cancer	0.000462	0.000779	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MC2R—prostate cancer	0.00046	0.00187	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RALBP1—prostate cancer	0.00046	0.00187	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HIST1H2BG—prostate cancer	0.00046	0.00187	CbGpPWpGaD
Etidronic acid—Constipation—Etoposide—prostate cancer	0.000459	0.000773	CcSEcCtD
Etidronic acid—Arthralgia—Capecitabine—prostate cancer	0.00045	0.000758	CcSEcCtD
Etidronic acid—Confusional state—Docetaxel—prostate cancer	0.00045	0.000757	CcSEcCtD
Etidronic acid—Discomfort—Capecitabine—prostate cancer	0.000445	0.000749	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HIST1H4H—prostate cancer	0.000444	0.0018	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NPPA—prostate cancer	0.000444	0.0018	CbGpPWpGaD
Etidronic acid—Infection—Docetaxel—prostate cancer	0.000443	0.000746	CcSEcCtD
Etidronic acid—Feeling abnormal—Etoposide—prostate cancer	0.000442	0.000745	CcSEcCtD
Etidronic acid—Diarrhoea—Mitoxantrone—prostate cancer	0.000441	0.000743	CcSEcCtD
Etidronic acid—Vomiting—Estradiol—prostate cancer	0.00044	0.000741	CcSEcCtD
Etidronic acid—Agranulocytosis—Epirubicin—prostate cancer	0.00044	0.000741	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Etoposide—prostate cancer	0.000439	0.000739	CcSEcCtD
Etidronic acid—Rash—Estradiol—prostate cancer	0.000437	0.000735	CcSEcCtD
Etidronic acid—Dermatitis—Estradiol—prostate cancer	0.000436	0.000734	CcSEcCtD
Etidronic acid—Anaemia—Prednisone—prostate cancer	0.000436	0.000733	CcSEcCtD
Etidronic acid—Confusional state—Capecitabine—prostate cancer	0.000435	0.000733	CcSEcCtD
Etidronic acid—Headache—Estradiol—prostate cancer	0.000434	0.00073	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000433	0.000729	CcSEcCtD
Etidronic acid—Angioedema—Prednisone—prostate cancer	0.000431	0.000725	CcSEcCtD
Etidronic acid—Infection—Capecitabine—prostate cancer	0.000429	0.000722	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000428	0.00072	CcSEcCtD
Etidronic acid—Urticaria—Etoposide—prostate cancer	0.000426	0.000718	CcSEcCtD
Etidronic acid—Abdominal pain—Etoposide—prostate cancer	0.000424	0.000714	CcSEcCtD
Etidronic acid—Nausea—Estradiol—prostate cancer	0.000411	0.000693	CcSEcCtD
Etidronic acid—Vomiting—Mitoxantrone—prostate cancer	0.00041	0.000691	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PENK—prostate cancer	0.00041	0.00167	CbGpPWpGaD
Etidronic acid—Agranulocytosis—Doxorubicin—prostate cancer	0.000407	0.000686	CcSEcCtD
Etidronic acid—Rash—Mitoxantrone—prostate cancer	0.000407	0.000685	CcSEcCtD
Etidronic acid—Dermatitis—Mitoxantrone—prostate cancer	0.000406	0.000684	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000406	0.000684	CcSEcCtD
Etidronic acid—Headache—Mitoxantrone—prostate cancer	0.000404	0.000681	CcSEcCtD
Etidronic acid—Arthralgia—Prednisone—prostate cancer	0.000401	0.000676	CcSEcCtD
Etidronic acid—Paraesthesia—Docetaxel—prostate cancer	0.0004	0.000674	CcSEcCtD
Etidronic acid—Erythema multiforme—Epirubicin—prostate cancer	0.0004	0.000674	CcSEcCtD
Etidronic acid—Discomfort—Prednisone—prostate cancer	0.000396	0.000668	CcSEcCtD
Etidronic acid—Hypersensitivity—Etoposide—prostate cancer	0.000395	0.000666	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000393	0.000662	CcSEcCtD
Etidronic acid—Dyspepsia—Docetaxel—prostate cancer	0.000393	0.000661	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GHR—prostate cancer	0.000391	0.00159	CbGpPWpGaD
Etidronic acid—Paraesthesia—Capecitabine—prostate cancer	0.000388	0.000653	CcSEcCtD
Etidronic acid—Nausea—Mitoxantrone—prostate cancer	0.000383	0.000645	CcSEcCtD
Etidronic acid—Infection—Prednisone—prostate cancer	0.000382	0.000643	CcSEcCtD
Etidronic acid—Constipation—Docetaxel—prostate cancer	0.000381	0.000642	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000381	0.00155	CbGpPWpGaD
Etidronic acid—Dyspepsia—Capecitabine—prostate cancer	0.00038	0.00064	CcSEcCtD
Etidronic acid—Pruritus—Etoposide—prostate cancer	0.00038	0.000639	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—B2M—prostate cancer	0.000377	0.00153	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFBR1—prostate cancer	0.000377	0.00153	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRP1—prostate cancer	0.000375	0.00152	CbGpPWpGaD
Etidronic acid—Alopecia—Epirubicin—prostate cancer	0.000374	0.00063	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—RPS19—prostate cancer	0.000371	0.00151	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKR1C3—prostate cancer	0.000371	0.00151	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Doxorubicin—prostate cancer	0.00037	0.000624	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PRKACB—prostate cancer	0.000369	0.0015	CbGpPWpGaD
Etidronic acid—Constipation—Capecitabine—prostate cancer	0.000369	0.000622	CcSEcCtD
Etidronic acid—Erythema—Epirubicin—prostate cancer	0.000369	0.000621	CcSEcCtD
Etidronic acid—Feeling abnormal—Docetaxel—prostate cancer	0.000368	0.000619	CcSEcCtD
Etidronic acid—Diarrhoea—Etoposide—prostate cancer	0.000367	0.000618	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Docetaxel—prostate cancer	0.000365	0.000614	CcSEcCtD
Etidronic acid—Flatulence—Epirubicin—prostate cancer	0.000363	0.000612	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PPP3CA—prostate cancer	0.00036	0.00146	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Capecitabine—prostate cancer	0.000356	0.000599	CcSEcCtD
Etidronic acid—Muscle spasms—Epirubicin—prostate cancer	0.000354	0.000597	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Capecitabine—prostate cancer	0.000353	0.000595	CcSEcCtD
Etidronic acid—Abdominal pain—Docetaxel—prostate cancer	0.000353	0.000594	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Prednisone—prostate cancer	0.00035	0.00059	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—VIP—prostate cancer	0.000349	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GNRH1—prostate cancer	0.000349	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PRKCZ—prostate cancer	0.000348	0.00141	CbGpPWpGaD
Etidronic acid—Alopecia—Doxorubicin—prostate cancer	0.000346	0.000583	CcSEcCtD
Etidronic acid—Paraesthesia—Prednisone—prostate cancer	0.000345	0.000582	CcSEcCtD
Etidronic acid—Urticaria—Capecitabine—prostate cancer	0.000343	0.000578	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CALR—prostate cancer	0.000342	0.00139	CbGpPWpGaD
Etidronic acid—Abdominal pain—Capecitabine—prostate cancer	0.000341	0.000575	CcSEcCtD
Etidronic acid—Vomiting—Etoposide—prostate cancer	0.000341	0.000575	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—prostate cancer	0.000341	0.000574	CcSEcCtD
Etidronic acid—Anaemia—Epirubicin—prostate cancer	0.000341	0.000574	CcSEcCtD
Etidronic acid—Dyspepsia—Prednisone—prostate cancer	0.000339	0.00057	CcSEcCtD
Etidronic acid—Rash—Etoposide—prostate cancer	0.000338	0.00057	CcSEcCtD
Etidronic acid—Dermatitis—Etoposide—prostate cancer	0.000338	0.000569	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GRP—prostate cancer	0.000338	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LPAR1—prostate cancer	0.000338	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGFR4—prostate cancer	0.000336	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PARP1—prostate cancer	0.000336	0.00137	CbGpPWpGaD
Etidronic acid—Headache—Etoposide—prostate cancer	0.000336	0.000566	CcSEcCtD
Etidronic acid—Flatulence—Doxorubicin—prostate cancer	0.000336	0.000566	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PLCB2—prostate cancer	0.000334	0.00136	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LRP2—prostate cancer	0.000334	0.00136	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CALCA—prostate cancer	0.000332	0.00135	CbGpPWpGaD
Etidronic acid—Leukopenia—Epirubicin—prostate cancer	0.00033	0.000556	CcSEcCtD
Etidronic acid—Constipation—Prednisone—prostate cancer	0.000329	0.000554	CcSEcCtD
Etidronic acid—Hypersensitivity—Docetaxel—prostate cancer	0.000329	0.000553	CcSEcCtD
Etidronic acid—Muscle spasms—Doxorubicin—prostate cancer	0.000328	0.000552	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CX3CL1—prostate cancer	0.000328	0.00133	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—P4HB—prostate cancer	0.000328	0.00133	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000322	0.00131	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GRB7—prostate cancer	0.000319	0.0013	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PDE4D—prostate cancer	0.000319	0.0013	CbGpPWpGaD
Etidronic acid—Nausea—Etoposide—prostate cancer	0.000319	0.000537	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HSPA1A—prostate cancer	0.000319	0.00129	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Capecitabine—prostate cancer	0.000318	0.000536	CcSEcCtD
Etidronic acid—Feeling abnormal—Prednisone—prostate cancer	0.000317	0.000534	CcSEcCtD
Etidronic acid—Pruritus—Docetaxel—prostate cancer	0.000316	0.000531	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—prostate cancer	0.000315	0.000531	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Prednisone—prostate cancer	0.000315	0.00053	CcSEcCtD
Etidronic acid—Arthralgia—Epirubicin—prostate cancer	0.000314	0.000528	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HIST1H4H—prostate cancer	0.000311	0.00126	CbGpPWpGaD
Etidronic acid—Discomfort—Epirubicin—prostate cancer	0.00031	0.000522	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CASP9—prostate cancer	0.000306	0.00124	CbGpPWpGaD
Etidronic acid—Urticaria—Prednisone—prostate cancer	0.000306	0.000515	CcSEcCtD
Etidronic acid—Pruritus—Capecitabine—prostate cancer	0.000306	0.000514	CcSEcCtD
Etidronic acid—Leukopenia—Doxorubicin—prostate cancer	0.000305	0.000514	CcSEcCtD
Etidronic acid—Diarrhoea—Docetaxel—prostate cancer	0.000305	0.000514	CcSEcCtD
Etidronic acid—Abdominal pain—Prednisone—prostate cancer	0.000304	0.000512	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GNG5—prostate cancer	0.000303	0.00123	CbGpPWpGaD
Etidronic acid—Confusional state—Epirubicin—prostate cancer	0.000303	0.000511	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000303	0.00123	CbGpPWpGaD
Etidronic acid—Infection—Epirubicin—prostate cancer	0.000299	0.000503	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PRKCQ—prostate cancer	0.000296	0.0012	CbGpPWpGaD
Etidronic acid—Diarrhoea—Capecitabine—prostate cancer	0.000295	0.000497	CcSEcCtD
Etidronic acid—Arthralgia—Doxorubicin—prostate cancer	0.00029	0.000489	CcSEcCtD
Etidronic acid—Discomfort—Doxorubicin—prostate cancer	0.000287	0.000483	CcSEcCtD
Etidronic acid—Vomiting—Docetaxel—prostate cancer	0.000284	0.000477	CcSEcCtD
Etidronic acid—Hypersensitivity—Prednisone—prostate cancer	0.000283	0.000477	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGF10—prostate cancer	0.000281	0.00114	CbGpPWpGaD
Etidronic acid—Rash—Docetaxel—prostate cancer	0.000281	0.000474	CcSEcCtD
Etidronic acid—Dermatitis—Docetaxel—prostate cancer	0.000281	0.000473	CcSEcCtD
Etidronic acid—Confusional state—Doxorubicin—prostate cancer	0.000281	0.000473	CcSEcCtD
Etidronic acid—Headache—Docetaxel—prostate cancer	0.000279	0.00047	CcSEcCtD
Etidronic acid—Infection—Doxorubicin—prostate cancer	0.000277	0.000466	CcSEcCtD
Etidronic acid—Vomiting—Capecitabine—prostate cancer	0.000275	0.000462	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000274	0.000461	CcSEcCtD
Etidronic acid—Rash—Capecitabine—prostate cancer	0.000272	0.000458	CcSEcCtD
Etidronic acid—Pruritus—Prednisone—prostate cancer	0.000272	0.000458	CcSEcCtD
Etidronic acid—Dermatitis—Capecitabine—prostate cancer	0.000272	0.000458	CcSEcCtD
Etidronic acid—Headache—Capecitabine—prostate cancer	0.000271	0.000455	CcSEcCtD
Etidronic acid—Paraesthesia—Epirubicin—prostate cancer	0.00027	0.000455	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TGFBR2—prostate cancer	0.000268	0.00109	CbGpPWpGaD
Etidronic acid—Nausea—Docetaxel—prostate cancer	0.000265	0.000446	CcSEcCtD
Etidronic acid—Dyspepsia—Epirubicin—prostate cancer	0.000265	0.000446	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTHLH—prostate cancer	0.000264	0.00107	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFBR1—prostate cancer	0.000264	0.00107	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ITPR1—prostate cancer	0.000263	0.00107	CbGpPWpGaD
Etidronic acid—Diarrhoea—Prednisone—prostate cancer	0.000263	0.000443	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—AKR1C3—prostate cancer	0.00026	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PRKACB—prostate cancer	0.000259	0.00105	CbGpPWpGaD
Etidronic acid—Constipation—Epirubicin—prostate cancer	0.000257	0.000433	CcSEcCtD
Etidronic acid—Nausea—Capecitabine—prostate cancer	0.000256	0.000432	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000254	0.000427	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PPP3CA—prostate cancer	0.000252	0.00102	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—THBS1—prostate cancer	0.000252	0.00102	CbGpPWpGaD
Etidronic acid—Paraesthesia—Doxorubicin—prostate cancer	0.00025	0.000421	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—ANXA1—prostate cancer	0.000248	0.00101	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Epirubicin—prostate cancer	0.000248	0.000417	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Epirubicin—prostate cancer	0.000246	0.000414	CcSEcCtD
Etidronic acid—Dyspepsia—Doxorubicin—prostate cancer	0.000245	0.000413	CcSEcCtD
Etidronic acid—Vomiting—Prednisone—prostate cancer	0.000245	0.000412	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PRKCZ—prostate cancer	0.000244	0.00099	CbGpPWpGaD
Etidronic acid—Rash—Prednisone—prostate cancer	0.000243	0.000408	CcSEcCtD
Etidronic acid—Dermatitis—Prednisone—prostate cancer	0.000242	0.000408	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—LPL—prostate cancer	0.000241	0.00098	CbGpPWpGaD
Etidronic acid—Headache—Prednisone—prostate cancer	0.000241	0.000406	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PDGFRB—prostate cancer	0.000239	0.000971	CbGpPWpGaD
Etidronic acid—Urticaria—Epirubicin—prostate cancer	0.000239	0.000402	CcSEcCtD
Etidronic acid—Constipation—Doxorubicin—prostate cancer	0.000238	0.000401	CcSEcCtD
Etidronic acid—Abdominal pain—Epirubicin—prostate cancer	0.000238	0.0004	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PARP1—prostate cancer	0.000236	0.000956	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGFR4—prostate cancer	0.000236	0.000956	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CALCA—prostate cancer	0.000233	0.000945	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERCC2—prostate cancer	0.000231	0.000939	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Doxorubicin—prostate cancer	0.000229	0.000386	CcSEcCtD
Etidronic acid—Nausea—Prednisone—prostate cancer	0.000228	0.000385	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000228	0.000383	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL12—prostate cancer	0.000227	0.000923	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB3—prostate cancer	0.000226	0.000918	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGFR2—prostate cancer	0.000226	0.000917	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Epirubicin—prostate cancer	0.000222	0.000373	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—prostate cancer	0.000221	0.000372	CcSEcCtD
Etidronic acid—Abdominal pain—Doxorubicin—prostate cancer	0.00022	0.00037	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MTHFR—prostate cancer	0.000217	0.000883	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—prostate cancer	0.000217	0.00088	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP9—prostate cancer	0.000214	0.000869	CbGpPWpGaD
Etidronic acid—Pruritus—Epirubicin—prostate cancer	0.000213	0.000358	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PRKCQ—prostate cancer	0.000207	0.000842	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NGFR—prostate cancer	0.000207	0.000842	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HIF1A—prostate cancer	0.000207	0.000842	CbGpPWpGaD
Etidronic acid—Diarrhoea—Epirubicin—prostate cancer	0.000206	0.000347	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—prostate cancer	0.000205	0.000345	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MAP3K7—prostate cancer	0.000205	0.000832	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CAV1—prostate cancer	0.0002	0.000814	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF10—prostate cancer	0.000197	0.0008	CbGpPWpGaD
Etidronic acid—Pruritus—Doxorubicin—prostate cancer	0.000197	0.000332	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—ADRB2—prostate cancer	0.000195	0.000792	CbGpPWpGaD
Etidronic acid—Vomiting—Epirubicin—prostate cancer	0.000191	0.000322	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—prostate cancer	0.00019	0.000321	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—VAV3—prostate cancer	0.00019	0.000772	CbGpPWpGaD
Etidronic acid—Rash—Epirubicin—prostate cancer	0.00019	0.000319	CcSEcCtD
Etidronic acid—Dermatitis—Epirubicin—prostate cancer	0.000189	0.000319	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—BAD—prostate cancer	0.000189	0.000766	CbGpPWpGaD
Etidronic acid—Headache—Epirubicin—prostate cancer	0.000188	0.000317	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFBR2—prostate cancer	0.000187	0.000761	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ITPR1—prostate cancer	0.000184	0.000749	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—APC—prostate cancer	0.000183	0.000742	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IRS1—prostate cancer	0.000181	0.000733	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGF—prostate cancer	0.000181	0.000733	CbGpPWpGaD
Etidronic acid—Nausea—Epirubicin—prostate cancer	0.000179	0.000301	CcSEcCtD
Etidronic acid—Vomiting—Doxorubicin—prostate cancer	0.000177	0.000298	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1R—prostate cancer	0.000176	0.000716	CbGpPWpGaD
Etidronic acid—Rash—Doxorubicin—prostate cancer	0.000175	0.000296	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—prostate cancer	0.000175	0.000295	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—GSK3B—prostate cancer	0.000175	0.000712	CbGpPWpGaD
Etidronic acid—Headache—Doxorubicin—prostate cancer	0.000174	0.000294	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—INS—prostate cancer	0.000173	0.000702	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CREBBP—prostate cancer	0.000169	0.000688	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LPL—prostate cancer	0.000169	0.000686	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFRB—prostate cancer	0.000168	0.00068	CbGpPWpGaD
Etidronic acid—Nausea—Doxorubicin—prostate cancer	0.000165	0.000278	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—ITGB3—prostate cancer	0.000163	0.000663	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAP2K1—prostate cancer	0.000162	0.000656	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CD—prostate cancer	0.000161	0.000652	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SERPINE1—prostate cancer	0.000159	0.000645	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB3—prostate cancer	0.000158	0.000643	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGFR2—prostate cancer	0.000158	0.000642	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGF2—prostate cancer	0.000154	0.000624	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—prostate cancer	0.000152	0.000616	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NOS3—prostate cancer	0.000152	0.000616	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—JAK2—prostate cancer	0.000147	0.000598	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HIF1A—prostate cancer	0.000145	0.000589	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MDM2—prostate cancer	0.000144	0.000584	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB2—prostate cancer	0.000142	0.000576	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LEP—prostate cancer	0.000142	0.000575	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CAV1—prostate cancer	0.00014	0.00057	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CB—prostate cancer	0.00014	0.000568	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KDR—prostate cancer	0.000139	0.000564	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTGS2—prostate cancer	0.000139	0.000563	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ESR1—prostate cancer	0.000135	0.000549	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BAD—prostate cancer	0.000132	0.000536	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1B—prostate cancer	0.000131	0.000533	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—APC—prostate cancer	0.000128	0.000519	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CG—prostate cancer	0.000128	0.000519	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGF—prostate cancer	0.000126	0.000513	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IRS1—prostate cancer	0.000126	0.000513	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CTNNB1—prostate cancer	0.000124	0.000504	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GSK3B—prostate cancer	0.000123	0.000498	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1A—prostate cancer	0.000121	0.000492	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—INS—prostate cancer	0.000121	0.000492	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—prostate cancer	0.000121	0.000491	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CREBBP—prostate cancer	0.000119	0.000481	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1—prostate cancer	0.000117	0.000475	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EP300—prostate cancer	0.000115	0.000468	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAP2K1—prostate cancer	0.000113	0.00046	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CD—prostate cancer	0.000112	0.000456	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SRC—prostate cancer	0.000112	0.000455	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SERPINE1—prostate cancer	0.000111	0.000452	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT3—prostate cancer	0.000108	0.000439	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF2—prostate cancer	0.000108	0.000437	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOS3—prostate cancer	0.000106	0.000431	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JAK2—prostate cancer	0.000103	0.000419	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MDM2—prostate cancer	0.000101	0.000409	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—prostate cancer	0.0001	0.000408	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFB1—prostate cancer	0.0001	0.000407	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB2—prostate cancer	9.93e-05	0.000403	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGFR—prostate cancer	9.83e-05	0.000399	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CB—prostate cancer	9.8e-05	0.000398	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL8—prostate cancer	9.42e-05	0.000382	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KRAS—prostate cancer	9.28e-05	0.000377	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1B—prostate cancer	9.2e-05	0.000373	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP3—prostate cancer	9.01e-05	0.000366	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2—prostate cancer	9e-05	0.000365	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—prostate cancer	8.77e-05	0.000356	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CTNNB1—prostate cancer	8.69e-05	0.000353	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CA—prostate cancer	8.53e-05	0.000346	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP9—prostate cancer	8.52e-05	0.000346	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1A—prostate cancer	8.49e-05	0.000345	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—prostate cancer	8.47e-05	0.000344	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EP300—prostate cancer	8.07e-05	0.000328	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SRC—prostate cancer	7.85e-05	0.000319	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFA—prostate cancer	7.65e-05	0.000311	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT3—prostate cancer	7.57e-05	0.000307	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6—prostate cancer	7.55e-05	0.000307	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—prostate cancer	7.04e-05	0.000286	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFB1—prostate cancer	7.02e-05	0.000285	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT1—prostate cancer	6.97e-05	0.000283	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGFR—prostate cancer	6.88e-05	0.000279	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—prostate cancer	6.5e-05	0.000264	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CA—prostate cancer	5.97e-05	0.000243	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—prostate cancer	5.78e-05	0.000235	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6—prostate cancer	5.29e-05	0.000215	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT1—prostate cancer	4.88e-05	0.000198	CbGpPWpGaD
